OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA
Clinical trials for OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough ovarian cancers
Disease control OngoingThis study tests whether adding an experimental drug (AZD1775) to standard chemotherapy (gemcitabine) helps women with ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based treatments. About 124 women will be randomly assigned to receive eith…
Matched conditions: OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests whether combining two drugs—cediranib (which cuts off a tumor's blood supply) and olaparib (which blocks cancer cell repair)—works better than olaparib alone for people with certain ovarian, fallopian tube, peritoneal, or triple-negative breast cancers that have …
Matched conditions: OVARIAN SEROUS SURFACE PAPILLARY ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC